Pharma: "Politics have destroyed a lot of trust lately" - Roche is examining future investments in Germany
Roche Germany head Daniel Steiners is questioning future investments at the Germany location. He demands more planning security from the federal government.
Roche, a Swiss pharmaceutical company, has put all future investments in Germany on hold due to the German government's austerity measures in the healthcare sector. The company's Germany head, Daniel Steiners, expressed concerns that the government's policies have eroded trust in the industry and called for reliable framework conditions.
Existing investment decisions, such as a €600 million expansion of its Penzberg site in Bavaria, will proceed as planned. Steiners criticized the government's focus on short-term savings, saying a comprehensive strategy is needed to address the structural problems of the statutory health insurance system.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
